Plain-English translation of NCT06343974 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research is testing whether special ultrasound imaging combined with computer analysis can noninvasively detect when a baby has high insulin levels in the womb. Babies of mothers with type 1 diabetes often develop high insulin levels because of their mother's elevated blood sugar, which can lead to complications at birth. The study will compare ultrasound images from pregnant women with type 1 diabetes to images from healthy pregnancies to see if the computer can spot the difference.
Right now, doctors don't have a safe, noninvasive way to know if a baby has dangerously high insulin levels before birth. High fetal insulin is linked to serious problems like larger-than-normal babies, low blood sugar after birth, and breathing difficulties. A reliable ultrasound method could help doctors manage high-risk pregnancies better and prepare for potential complications at delivery.
You likely qualify if…
You likely don't qualify if…
You would have an ultrasound scan of your baby's liver at 34 weeks of pregnancy as part of your routine prenatal care. The ultrasound images would be analyzed using advanced computer technology to look for patterns that suggest high insulin levels. You would be in the study from enrollment through delivery, and no additional procedures or medications would be required beyond this special ultrasound imaging.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Finland
Sponsor
Turku University Hospital
Enrollment target
~60 participants
Started
October 2024
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 45 Years
Sex
Female only
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mikael Huhtala, M.D., Ph.D.
Turku University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.